Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Fuss Brands Corp. (CBP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/02/2023 |
8-K
| Entry into a Material Definitive Agreement, Change in Shell Company Status, Financial Statements and Exhibits &nbs... |
| 01/27/2023 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits Interactive Data |
| 12/05/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/26/2022 |
8-K
| Quarterly results |
| 08/25/2021 |
8-K
| Quarterly results |
| 02/17/2021 |
8-K
| Quarterly results |
| 06/06/2013 |
8-K
| Quarterly results |
| 05/07/2013 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 01/23/2013 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 01/15/2013 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 04/12/2012 |
8-K
| Form 8-K - Current report |
| 03/19/2012 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits |
| 03/15/2012 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"China Botanic Schedules Conference Call to Discuss Fiscal Year 2012 First Quarter Results HARBIN, CHINA – – China Botanic Pharmaceutical Inc. , a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines , today announced that it will host a conference call at 9:00 a.m. Eastern Time on Monday, March 19, 2012, to discuss financial results for the first quarter of fiscal year 2012 ended January 31, 2012. Joining Mr. Shaoming Li, China Botanic’ s chairman and CEO, will be Mr. Guangtao Li, the Company’ s vice president and Mr. David Dong, the Company’ s CFO. To participate in the conference call, please dial the following number five to ten minutes prior to the scheduled conference call time: 866-394-2209. International callers should ..." |
|
| 02/01/2012 |
8-K
| Form 8-K - Current report |
| 01/10/2012 |
8-K
| Form 8-K - Current report |
| 10/18/2011 |
8-K
| Form 8-K - Current report |
| 10/13/2011 |
8-K
| Other Events, Financial Statements and Exhibits |
| 03/18/2011 |
8-K
| Form 8-K - Current report |
| 03/17/2011 |
8-K
| Form 8-K - Current report |
| 02/09/2011 |
8-K
| Form 8-K - Current report |
| 01/25/2011 |
8-K
| Form 8-K - Current report |
| 12/22/2010 |
8-K
| Form 8-K - Current report |
| 12/02/2010 |
8-K
| Form 8-K - Current report |
| 09/21/2010 |
8-K
| Form 8-K - Current report |
| 08/26/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Renhuang Announces Appointment of Interim CFO Harbin, China – August 20, 2010 – Renhuang Pharmaceuticals, Inc. , a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines , today announced that, it has appointed Ms. Xiaoying Lu as its Interim Chief Financial Officer , while the Company seeks a permanent replacement. Reporting directly to Mr. Shaoming Li, the Company’s Chairman and Chief Executive Officer, Ms. Lu will be responsible for managing all financial functions, including, financial management, reporting, risk management and managing the financial budget, while Renhuang continues to search for a new CFO. Upon his or her appointment, Ms. Lu will transition to the role of an Assistant to the CFO to ensure a seamless transiti..." |
|
| 08/09/2010 |
8-K
| Form 8-K - Current report |
| 07/14/2010 |
8-K
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits|
Docs:
|
"Acquisition Agreement, with Yichun Red Star Forest Bureau, of Acanthopanax Resources",
"Renhuang Signs Exclusive Purchase Agreement for Siberian Ginseng Harbin, China – July 9, 2010 – Renhuang Pharmaceuticals, Inc. , a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines , today announced that on July 8, 2010, the Company signed an Acquisition Agreement with Yichun Red Star Forest Bureau of Heilongjiang Province for indefinite exclusive access to 100,000 acres of wild Siberian Ginseng in Heilongjiang Province. Siberian Ginseng is a plant with medically-established anti-depressant and mood regulation qualities and is also an active ingredient in the Company’s market-leading line of all-natural anti-depressant medications. Under the terms of the Agreement, Renhuang will be granted permanent exclusive rights to purc..." |
|
| 07/02/2010 |
8-K
| Other Events, Financial Statements and Exhibits|
Docs:
|
"Renhuang Pharmaceuticals Receives Approval to list on the NYSE Amex HARBIN, HEILONGJIANG, China, July 1, 2010 – Renhuang Pharmaceuticals, Inc. , a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced that the Company received approval to list its common stock on the NYSE Amex. Renhuang expects to begin trading on the NYSE Amex on Friday, July 2, 2010. In connection with the listing on NYSE Amex, Renhuang’s stock symbol will change to “CBP” from “RHGP”. “We are very pleased to move onto the NYSE Amex and begin our next phase as a public company,” said Mr. Shaoming Li, Chairman of the Board, Chief Executive Officer and President of Renhuang Pharmaceuticals, Inc. “We are honored to join the family of NYSE compani..." |
|
| 06/09/2010 |
8-K
| Quarterly results |
| 04/27/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/20/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/15/2010 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/17/2010 |
8-K
| Form 8-K - Current report |
| 03/04/2010 |
8-K
| Investor presentation|
Docs:
|
"Renhuang Announces Fiscal Year 2010 Guidance · Expect 26% to 28% revenue and net income growth Harbin, China – March 04, 2010 – Renhuang Pharmaceuticals, Inc. , a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines in China, today announced revenue and net income guidance for fiscal year 2010 ending October 31, 2010. Renhuang expects revenues for FY 2010 to be in the range of $54.7-$55.6 million, which represents a 26% to 28% increase over reported revenues of $43.4 million in fiscal year 2009. The Company expects FY 2010 net income to be in the range of $18.6-$18.9 million, up 26% to 28% from net income of $14.8 million in fiscal year 2009. “We anticipate strong organic growth in the top- and bottom-line to be driven by our ...",
"Copy of Company Presentation" |
|
|
|
|